What US FDA’s new surprise foreign inspections plan means for India
Pharma companies exporting to the US should now rightly be on guard and start…
Interviews
India needs to step up more as a strategic innovator in the global supply chain
In a free wheeling conversation, US-based Hari Kiran Chereddi, MD, HRV Global Life Sciences explains to Viveka Roychowdhury that…
We are well-aligned to capitalise on the CDMO opportunity
Dr Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions (LMS), explains to Viveka Roychowdhury how LMS is aligning long-term…
AI does not just make clinical trials faster; it makes them smarter
Santhosh A F, VP, Asia Pacific South & India, Medidata highlights how AI is improving the efficiency and speed of the clinical…
